| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |